Experimental Procedures
Cell Lines and Reagents− Rat cardiac H9c2 myoblasts, human MCF-7 breast carcinoma cells, and human HEK 293 cells were maintained in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS). Murine HL-1 cells, a well-differentiated cardiac myocyte cell line (29) , were kindly provided by Dr. William Claycomb and were grown in Ex-Cell 320 medium (JRH Biosciences, Lenexa, KS) supplemented with 10% FBS, 1 µM retinoic acid (Sigma), 10 µg/ml insulin (Invitrogen), 10 µM norepinephrine (Sigma), 1X non-essential amino acids (Invitrogen), and 50 µg/ml endothelial cell growth supplement (Upstate Biotechnology, Lake Placid, NY) as detailed elsewhere (29) . TNF-α was purchased from R&D Systems (Minneapolis, MN) and zVAD-fmk from Enzyme Systems Products (Livermore, CA). All other reagents were purchased from Sigma unless otherwise specified.
Desmin Plasmid Constructs− A mutant desmin construct specifically altered at a potential caspase cleavage site (D263E) was made using the QuickChange Site-Directed Mutagenesis kit (Stratagene) according to the manufacturer's instructions using wild-type murine desmin as a template and the following oligonucleotide primers: 5'-CCAGGTGGAGATGGAAATGTCCAA-GCCGG-3' and 5'-CCGGCTTGGACATTTCCATCTCCACCTGG-3'. To make FLAG-tagged constructs, full-length desmin and truncated desmin cDNAs encoding the amino-terminal caspase cleavage product (amino acids 1-263, designated N-desmin) or the carboxyl-terminal product (amino acids 264-469, designated C-desmin) were PCR amplified from murine desmin cDNA with the following primers: 5'-GGCGGAATTCATGAGCCAGGCCTACTCGTC-3' and 5'-GTGGGCGGCCGCTTACAGCACTTCATGTTGTT-3' (full-length), 5'-GGCGGAATTCATGAGCCAGGCCTACTCGTC-3' and 5'-GTGGGCGGCCGCCTAGTCCA-TCTCCACCTGGACC-3' (N-desmin), or 5'-GGCGGAATTCATGTCCAAGCCGGACCTCAC-3'
and 5'-GTGGGCGGCCGCTTACAGCACTTCATGTTGTT-3' (C-desmin). The PCR products were then digested with EcoRI and NotI and subcloned into these sites in pcDNA3-NFLAG. Each desmin construct was verified by DNA sequencing. at 37°C, and the cleavage products were analyzed as described previously (30, 31) . The enzymatic activity of each caspase was confirmed using a well-characterized substrate for each caspase as a positive control. To determine whether desmin mutant D263E was resistant to caspase cleavage in vitro, 35 S-labeled wild-type or mutant D263E desmin were incubated with 25 ng of recombinant caspase-6 and analyzed as above.
Immunoblot Analyses− Differentiated HL-1 cardiac myocytes were treated with 10 ng/ml TNF-α and 1µg/ml cycloheximide (CHX) for 0, 3, 6, 9 or 18 h. Whole cell lysates were analyzed by immunoblotting as described previously (30) using a desmin mAb (Sigma) or PKCδ polyclonal antibody (Santa Cruz Biotechnology). For inhibitor studies, H9c2 myoblasts were treated with 10 ng/ml TNF-α and 1µg/ml CHX for 24 h in the presence or absence of 50 µM zVAD-fmk. To determine whether the mutant D263E desmin protein was resistant to caspase proteolysis in vivo, HEK 293 cells were transfected with 1 µg of wild-type or mutant D263E desmin cDNA using Lipofectamine Plus Reagent (Invitrogen) according to the manufacturer's instructions. After overnight incubation, transfected HEK 293 cells were treated with 10 ng/ml TNF-α and 1µg/ml CHX for 24 h, and cell lysates were analyzed as above.
Indirect Immunofluorescence− H9c2 myoblasts were grown to approximately 80% confluence on glass coverslips and then transfected with 1 µg of pcDNA3-NFLAG plasmid encoding full-length desmin, the amino terminal caspase cleavage product (amino acids 1-263), or the carboxyl-terminal caspase cleavage product (amino acids 264-469) using Lipofectamine Plus Reagent (Invitrogen).
After 24-h incubation, cells were fixed in methanol for 2 minutes at -20°C, and sequentially pcDNA3-NFLAG-N-desmin and 0.4 µg pEGFPN1-vimentin (17) , and vimentin was visualized by GFP-fluorescence as described previously (17) .
Stable Transfection of MCF-7 Cells with cDNAs Encoding Wild-type or Mutant D263E Desmin
and Apoptosis Assays− MCF-7 cells were transfected with 1.2 µg of pcDNA3-wild-type desmin or pcDNA3-D263E desmin using Lipofectamine Plus Reagent (Invitrogen). After 48 h, cells stably expressing these desmin cDNAs were selected by adding 500 µg/ml G418 (Invitrogen) to the growth medium for 3 weeks. Stable expression was confirmed by immunoblotting with a desmin mAb (Sigma). MCF-7 cells stably expressing wild-type or mutant D263E desmin were then treated with 10 ng/ml TNF-α and 1 µg/ml CHX for 24 h, and nuclei were scored for apoptotic morphology (chromatin condensation or nuclear fragmentation) by staining with Hoescht no. 33258 as described (17) . 
Proteolysis of Desmin by Caspases at Asp 263 in Myogenic Cells
Undergoing Apoptosis− To determine whether desmin is cleaved by caspases in apoptotic myogenic cells, we treated differentiated HL-1 cardiac myocytes (29) with 10 ng/ml TNF-α and 1 µg/ml CHX for 0-18 h (CHX was added to sensitize these cells to the induction of apoptosis). As shown in Fig. 2A , desmin was cleaved into a product of approximately 27 kDa that was first observed some 9 h after treatment with TNF-α. The abundance of this proteolytic product increased with time, corresponding with a reduction in the amount of full-length desmin. Desmin was also cleaved into a similar sized product in differentiated HL-1 myocytes induced to undergo apoptosis by treatment with staurosporine (data not presented). Furthermore, the size of the observed apoptotic desmin cleavage product is similar to one of the desmin cleavage products generated by caspase-6 in vitro (the other product was not detected by the desmin mAb used in these studies), suggesting that caspase-6 might be the protease cleaving desmin during apoptosis in vivo. Interestingly, the TNF-α-induced proteolysis of the well-characterized caspase-3 substrate PKCδ (32) into its characteristic sized cleavage product (indicated by arrow) preceded that of desmin, consistent with caspase-3 being upstream of caspase-6 in the execution of apoptosis (33) . As demonstrated in Fig.   2B , the broad spectrum caspase inhibitor zVAD-fmk potently inhibited the production of the apoptotic desmin cleavage product in H9c2 myogenic cells treated with TNF-α and CHX, indicating that this proteolytic event in apoptotic myoblasts is indeed mediated by one or more caspases. Finally, WT desmin, but not the D263E mutant, was cleaved during TNF-α-induced apoptosis in HEK293 cells transiently transfected with the corresponding cDNAs (Fig. 2C ). These lower panels (Fig. 3A) . As shown in Fig. 3B , each of these desmin cDNAs was expressed at comparable levels in H9c2 myoblasts. N-desmin also inhibited the assembly of WT desmin in cotransfection experiments performed in desmin-deficient MCF-7 cells; C-desmin was not tested in this system because of its more subtle defect in filament assembly. As demonstrated in Fig. 3C , even small amounts of N-desmin potently disrupted the ability of WT desmin to assemble into filaments, instead promoting the formation of aggregates. Furthermore, N-desmin also interfered with the assembly of the structurally related intermediate filament protein vimentin (35) (Fig. 3D ).
These findings indicate that caspase cleavage of desmin has dramatic functional consequences, viz., the production of a truncated protein that interferes in a dominant negative fashion with the assembly of both desmin and vimentin filaments. We have also demonstrated that caspase proteolysis of desmin has profound effects on its ability to assemble into intermediate filaments. Indeed, the amino-terminal caspase cleavage product (N-desmin encoding amino acids 1-263) is completely unable to assemble into filaments and forms intracellular aggregates/inclusions. These desmin aggregates are morphologically very similar to those formed by caspase-cleaved cytokeratins and vimentin (13, 17, 37) . The cytokeratin aggregates have been studied most extensively and contain activated caspase-3, the putative scaffold proteins DEDD and DEDD2, and cytokeratins 8, 18 and 19, in addition to caspase-cleaved cytokeratin 18 (37, 38) . Although the other components of the aggregates formed by N-desmin are currently unknown, they likely contain the small heat shock protein αB-crystallin, a molecular chaperone which binds to desmin and other intermediate filament proteins (39) . Interestingly, mutations in 
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